Abbott Labs (ABT) PT Raised to $92 at RBC Capital
Tweet
Share
E-mail
Get Alerts ABT Hot Sheet
Price: $116.64 +2.19%
Rating Summary:
26 Buy, 9 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
26 Buy, 9 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
RBC Capital analyst Glenn Novarro raised the price target on Abbott Labs (NYSE: ABT) to $92.00 (from $82.00) while maintaining an Outperform rating following results.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Abbott Labs (ABT) PT Raised to $135 at TD Cowen
- Beike (BEKE) PT Raised to $23 at Morgan Stanley
- Agilent (A) PT Raised to $150 at Jefferies
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
RBC CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
